Obesity Trial, Recruiting NCT04752293 Sponsor: Wake Forest University Health Sciences Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04752293
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has two separate groups — one for children and teenagers with high blood pressure (hypertension), and one for those with normal blood pressure (the comparison group). Criteria are listed for each.


HYPERTENSION GROUP

Who might be able to join this trial:

  • Children and teenagers between 7 and 18 years old at the time of joining.
  • Those who have recently been diagnosed with high blood pressure that has no known underlying cause, and who have been referred to a hypertension or kidney specialist clinic — for children under 13, this means blood pressure at or above a certain level for their age and size; for those 13 and older, this means blood pressure at or above 130/80 mmHg (confirm exact thresholds with trial site).
  • The child and their caregiver must both be willing and able to attend and complete all study visits and assessments.

Who may not be able to join:

  • Children younger than 7 or older than 18 at the time of joining.
  • Those whose blood pressure has been confirmed as normal or only mildly elevated (but not high enough to meet the hypertension threshold) across three or more separate clinic visits.
  • Those whose high blood pressure has a confirmed underlying medical cause (such as a kidney or hormonal condition).
  • Those with certain other serious health conditions, such as heart disease, kidney disease (except for specific heart or kidney changes caused by high blood pressure), blood vessel or inflammatory disease, or diabetes.
  • Those who would be unable to complete the study assessments.
  • Those who do not speak English or Spanish.
  • Those who are currently pregnant.
  • Those who are a Ward of the State (a child under government guardianship).

CONTROL (NORMAL BLOOD PRESSURE) GROUP

Who might be able to join this trial:

  • Children and teenagers between 7 and 18 years old at the time of joining.
  • Those whose blood pressure has been confirmed as normal across three or more separate clinic visits — for children under 13, this means blood pressure below a certain level for their age and size; for those 13 and older, this means blood pressure below 120/80 mmHg (confirm exact thresholds with trial site).
  • The child and their caregiver must both be willing and able to attend and complete all study visits and assessments.

Who may not be able to join:

  • Children younger than 7 or older than 18 at the time of joining.
  • Those whose blood pressure is elevated or meets the definition of high blood pressure across three or more separate clinic visits.
  • Those with a past history of elevated or high blood pressure.
  • Those currently taking any medication to lower blood pressure.
  • Those with certain other serious health conditions, such as heart disease, kidney disease, blood vessel or inflammatory disease, or diabetes.
  • Those who would be unable to complete the study assessments.
  • Those who do not speak English or Spanish.
  • Those who are currently pregnant.
  • Those who are a Ward of the State (a child under government guardianship).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew M South, MD, MS, Wake Forest Health Sciences

Phone: 336.716.9640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 May 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Baseline Urine Angiotensin-(1-7)/Creatinine Ratio; Change in Urine Angiotensin-(1-7)/Creatinine Ratio; Baseline Urine Angiotensin II/Angiotensin-(1-7) Ratio; Change in Urine Angiotensin II/Angiotensin-(1-7) Ratio; Baseline Plasma Angiotensin-(1-7) Level; Change in Plasma Angiotensin-(1-7) Level; Baseline Plasma Angiotensin II/Angiotensin-(1-7) Ratio; Change in Plasma Angiotensin II/Angiotensin-(1-7) Ratio; Baseline Serum Uric Acid Level; Change in Serum Uric Acid Level; Baseline Plasma Klotho Level; Change in Plasma Klotho Level; Baseline Urine Klotho/Creatinine Ratio; Change in Urine Klotho/C...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov